RISEDRONATE SODIUM

RISEDRONATE SODIUM was reported 31232 times

RISEDRONATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 67 0.4497
1 EOSINOPHILIC BRONCHITIS 80 0.4000
2 PRESBYACUSIS 119 0.3864
3 SALPINGO-OOPHORECTOMY UNILATERAL 42 0.3818
4 FRACTURE DISPLACEMENT 154 0.3590
5 HYPOCHOLESTEROLAEMIA 103 0.2918
6 C-REACTIVE PROTEIN 261 0.2816
7 RED BLOOD CELL SEDIMENTATION RATE 76 0.2724
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 491 0.2451
9 LUPUS VULGARIS 270 0.2143
10 ANKLE ARTHROPLASTY 71 0.1956
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 130 0.1946
12 SWOLLEN JOINT COUNT INCREASED 616 0.1930
13 SWOLLEN JOINT COUNT 45 0.1800
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 359 0.1731
15 RHEUMATOID FACTOR POSITIVE 991 0.1714
16 GRANULOMA SKIN 137 0.1669
17 DISLOCATION OF VERTEBRA 364 0.1594
18 RHEUMATIC FEVER 695 0.1558
19 COMMINUTED FRACTURE 50 0.1502
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1058 0.1475
21 NASAL OEDEMA 259 0.1433
22 PLEURAL THICKENING 94 0.1374
23 FACET JOINT SYNDROME 424 0.1301
24 LOW TURNOVER OSTEOPATHY 517 0.1293
25 BLOOD PRESSURE DIASTOLIC ABNORMAL 327 0.1284
26 PLEURAL FIBROSIS 129 0.1266
27 PERIPHERAL VENOUS DISEASE 517 0.1265
28 X-RAY ABNORMAL 223 0.1246
29 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 96 0.1203
30 JOINT DESTRUCTION 187 0.1202
31 BLOOD PRESSURE SYSTOLIC ABNORMAL 294 0.1188
32 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 258 0.1119
33 FRACTURE DELAYED UNION 91 0.1077
34 BLOOD PARATHYROID HORMONE DECREASED 158 0.1065
35 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 98 0.1057
36 C-REACTIVE PROTEIN ABNORMAL 667 0.1039
37 DUODENAL ULCER PERFORATION 771 0.1036
38 BLOOD MAGNESIUM INCREASED 92 0.1020
39 RHEUMATOID NODULE 280 0.1016
40 ATYPICAL FEMUR FRACTURE 283 0.1002
41 OSTEOGENESIS IMPERFECTA 54 0.0926
42 FRACTURE NONUNION 122 0.0892
43 DRUG TOLERANCE DECREASED 250 0.0889
44 PEMPHIGUS 1101 0.0880
45 RETINITIS 145 0.0839
46 CONGESTIVE HEPATOPATHY 37 0.0826
47 SYNOVITIS 1453 0.0805
48 STRESS FRACTURE 425 0.0787
49 MUSCLE INJURY 651 0.0785
50 ENDOMETRIAL DISORDER 32 0.0775
51 OPEN REDUCTION OF FRACTURE 87 0.0759
52 ANAEMIA POSTOPERATIVE 98 0.0750
53 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 42 0.0749
54 HELICOBACTER INFECTION 751 0.0730
55 MULTIPLE DRUG THERAPY 55 0.0729
56 HAND DEFORMITY 949 0.0723
57 BONE EROSION 250 0.0706
58 INTRAMEDULLARY ROD INSERTION 144 0.0702
59 BREAST CANCER STAGE III 454 0.0700
60 ATYPICAL FRACTURE 43 0.0698
61 BUNION OPERATION 39 0.0695
62 PANNICULITIS 163 0.0673
63 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 437 0.0672
64 BONE CYST 63 0.0672
65 FOLLICULITIS 685 0.0653
66 LIP DRY 589 0.0648
67 TOTAL LUNG CAPACITY DECREASED 102 0.0638
68 SERONEGATIVE ARTHRITIS 72 0.0628
69 BURSITIS 760 0.0626
70 SINUSITIS FUNGAL 50 0.0623
71 ATROPHIC VULVOVAGINITIS 45 0.0616
72 PRIMARY SEQUESTRUM 54 0.0596
73 RHEUMATOID LUNG 56 0.0586
74 PORPHYRIA ACUTE 83 0.0578
75 PERICARDITIS 971 0.0577
76 ENTHESOPATHY 88 0.0562
77 RESORPTION BONE INCREASED 46 0.0561
78 JOINT RANGE OF MOTION DECREASED 726 0.0541
79 WOUND INFECTION 592 0.0540
80 OSTEOSCLEROSIS 84 0.0533
81 ALANINE AMINOTRANSFERASE ABNORMAL 109 0.0516
82 BLEPHAROSPASM 324 0.0514
83 GRANULOMATOSIS WITH POLYANGIITIS 62 0.0514
84 ENTEROCOCCUS TEST POSITIVE 32 0.0494
85 PATHOLOGICAL FRACTURE 249 0.0490
86 PULMONARY FIBROSIS 936 0.0487
87 OVERLAP SYNDROME 34 0.0486
88 AUTOIMMUNE DISORDER 468 0.0480
89 LIVE BIRTH 391 0.0467
90 DRUG TOLERANCE 235 0.0464
91 PERIODONTAL DISEASE 64 0.0456
92 CALCIUM DEFICIENCY 59 0.0455
93 LIMB ASYMMETRY 35 0.0455
94 ULNA FRACTURE 45 0.0454
95 RED BLOOD CELL SEDIMENTATION RATE INCREASED 494 0.0446
96 FOOT DEFORMITY 474 0.0427
97 GLOSSODYNIA 953 0.0425
98 BONE GRAFT 39 0.0418
99 ULCER HAEMORRHAGE 281 0.0415
100 FEMUR FRACTURE 1280 0.0413
101 BLOOD PRESSURE DIASTOLIC DECREASED 305 0.0413
102 FIBROMYALGIA 994 0.0408
103 GRIP STRENGTH DECREASED 359 0.0407
104 SCIATICA 646 0.0405
105 DEAFNESS NEUROSENSORY 133 0.0404
106 POLYARTHRITIS 213 0.0404
107 HYPERCHOLESTEROLAEMIA 386 0.0399
108 CONTRAINDICATED PRODUCT ADMINISTERED 1209 0.0399
109 TENOSYNOVITIS 106 0.0384
110 BLOOD PRESSURE SYSTOLIC INCREASED 748 0.0383
111 OBESITY 597 0.0374
112 LOWER LIMB FRACTURE 713 0.0371
113 LIVER INJURY 909 0.0370
114 PERIPHERAL SENSORIMOTOR NEUROPATHY 46 0.0366
115 LUNG OPACITY 96 0.0364
116 WOUND 1009 0.0361
117 OSTEOARTHRITIS 1499 0.0353
118 IRRITABLE BOWEL SYNDROME 753 0.0351
119 OEDEMA 1898 0.0350
120 JAW DISORDER 190 0.0347
121 BLOOD PRESSURE DIASTOLIC INCREASED 160 0.0346
122 WHEEZING 2014 0.0339
123 EXOSTOSIS 308 0.0337
124 LUMBAR RADICULOPATHY 38 0.0328
125 PLEURITIC PAIN 90 0.0326
126 TYPE 2 DIABETES MELLITUS 1097 0.0326
127 EPIGASTRIC DISCOMFORT 126 0.0322
128 IMPAIRED HEALING 1041 0.0317
129 SKIN NECROSIS 159 0.0306
130 BREATH SOUNDS ABNORMAL 151 0.0306
131 RALES 176 0.0303
132 ARTHROPATHY 1652 0.0297
133 NAIL DISORDER 260 0.0297
134 PRESCRIBED OVERDOSE 574 0.0296
135 RESPIRATORY SYMPTOM 84 0.0295
136 SYSTEMIC LUPUS ERYTHEMATOSUS 1047 0.0295
137 FEMALE GENITAL TRACT FISTULA 49 0.0287
138 EYE INJURY 87 0.0286
139 WALKING AID USER 187 0.0283
140 BRONCHIECTASIS 187 0.0277
141 OBSTRUCTIVE AIRWAYS DISORDER 308 0.0277
142 FOOT OPERATION 135 0.0273
143 PERIODONTITIS 59 0.0272
144 PSORIATIC ARTHROPATHY 1101 0.0271
145 OSTEOPENIA 404 0.0266
146 SPONDYLOLISTHESIS 46 0.0265
147 RADIUS FRACTURE 63 0.0262
148 MEDICAL DEVICE REMOVAL 45 0.0260
149 FRACTURED SACRUM 32 0.0257
150 DIASTOLIC DYSFUNCTION 79 0.0256
151 FISTULA DISCHARGE 32 0.0253
152 BREAST CANCER STAGE II 210 0.0252
153 NODULE 327 0.0250
154 VITAMIN B12 DECREASED 72 0.0250
155 OSTEOPOROSIS 1027 0.0249
156 IMMOBILE 109 0.0249
157 PHARYNGEAL PARAESTHESIA 39 0.0246
158 NAIL INFECTION 34 0.0237
159 ENDODONTIC PROCEDURE 60 0.0236
160 SPUTUM INCREASED 51 0.0236
161 LOWER RESPIRATORY TRACT CONGESTION 40 0.0235
162 BLOOD CHOLESTEROL INCREASED 1080 0.0231
163 INFUSION RELATED REACTION 1534 0.0231
164 LOWER RESPIRATORY TRACT INFECTION 1044 0.0229
165 HIP ARTHROPLASTY 349 0.0228
166 BONE DISORDER 412 0.0226
167 THERAPEUTIC PRODUCT EFFECT DECREASED 1003 0.0224
168 JAW FRACTURE 48 0.0222
169 THORACIC VERTEBRAL FRACTURE 65 0.0219
170 OSTEOPOROTIC FRACTURE 42 0.0219
171 DIVERTICULUM 155 0.0218
172 RHEUMATOID ARTHRITIS 2470 0.0217
173 NIGHT SWEATS 699 0.0217
174 MOBILITY DECREASED 1556 0.0216
175 MYELOPATHY 41 0.0216
176 KYPHOSIS 38 0.0215
177 SCLERITIS 34 0.0212
178 LOOSE TOOTH 68 0.0211
179 TEMPOROMANDIBULAR JOINT SYNDROME 56 0.0209
180 JOINT EFFUSION 144 0.0209
181 SPINAL OSTEOARTHRITIS 183 0.0208
182 GRANULOMA 72 0.0208
183 MATERNAL EXPOSURE TIMING UNSPECIFIED 78 0.0207
184 PRESCRIBED UNDERDOSE 414 0.0207
185 C-REACTIVE PROTEIN INCREASED 755 0.0207
186 SPONDYLITIS 75 0.0206
187 AORTIC ARTERIOSCLEROSIS 53 0.0206
188 LUMBAR SPINAL STENOSIS 60 0.0205
189 FIBROSIS 63 0.0205
190 ADRENAL INSUFFICIENCY 246 0.0203
191 WHEELCHAIR USER 88 0.0198
192 BLOOD PRESSURE FLUCTUATION 475 0.0198
193 FOOT FRACTURE 372 0.0196
194 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 40 0.0196
195 JOINT DISLOCATION 205 0.0194
196 HUMERUS FRACTURE 93 0.0193
197 EXERCISE TOLERANCE DECREASED 110 0.0191
198 INFUSION SITE REACTION 57 0.0191
199 RESPIRATORY TRACT INFECTION 495 0.0190
200 SPINAL COMPRESSION FRACTURE 157 0.0190
201 INTERVERTEBRAL DISC DEGENERATION 175 0.0189
202 ASTHMA 2116 0.0187
203 ONYCHOMYCOSIS 82 0.0187
204 OSTEITIS 47 0.0186
205 ONYCHOMADESIS 78 0.0186
206 POLYMYALGIA RHEUMATICA 59 0.0186
207 BODY TEMPERATURE DECREASED 182 0.0185
208 UTERINE DISORDER 43 0.0184
209 TASTE DISORDER 374 0.0184
210 CHRONIC SINUSITIS 69 0.0184
211 OSTEONECROSIS OF JAW 449 0.0181
212 PELVIC FRACTURE 141 0.0181
213 ATROPHY 35 0.0180
214 MUSCULOSKELETAL PAIN 942 0.0180
215 DYSLIPIDAEMIA 90 0.0177
216 SPUTUM DISCOLOURED 168 0.0177
217 ORAL INFECTION 69 0.0176
218 HYPERCALCAEMIA 218 0.0176
219 JOINT SWELLING 2114 0.0175
220 ESSENTIAL HYPERTENSION 32 0.0175
221 IMMUNODEFICIENCY 260 0.0174
222 POLYP 114 0.0174
223 MUSCULOSKELETAL STIFFNESS 1523 0.0174
224 HEPATIC ENZYME INCREASED 1168 0.0171
225 HYPERPARATHYROIDISM 35 0.0170
226 GAIT INABILITY 567 0.0169
227 DRUG INTOLERANCE 1632 0.0169
228 BASAL CELL CARCINOMA 263 0.0168
229 KNEE ARTHROPLASTY 354 0.0168
230 FINGER DEFORMITY 81 0.0167
231 LUNG DISORDER 819 0.0167
232 EOSINOPHIL COUNT INCREASED 139 0.0167
233 GINGIVAL DISORDER 64 0.0166
234 PNEUMOCYSTIS JIROVECI PNEUMONIA 37 0.0166
235 BLISTER 931 0.0166
236 EMBOLISM VENOUS 50 0.0165
237 SYNOVIAL CYST 76 0.0164
238 INFLAMMATION 844 0.0163
239 GASTROOESOPHAGEAL REFLUX DISEASE 1299 0.0161
240 TOOTH DISORDER 358 0.0161
241 BONE DENSITY ABNORMAL 60 0.0160
242 DISCOMFORT 977 0.0160
243 NEUTROPHILIA 91 0.0160
244 DENTAL CARIES 175 0.0158
245 CHEST X-RAY ABNORMAL 48 0.0156
246 ULCER 248 0.0156
247 THERAPY NON-RESPONDER 699 0.0155
248 VITAMIN D DEFICIENCY 151 0.0155
249 OSTEOMYELITIS 280 0.0154
250 SPINAL COLUMN STENOSIS 73 0.0154
251 LIVER DISORDER 681 0.0153
252 BEDRIDDEN 198 0.0150
253 GROIN PAIN 132 0.0150
254 GINGIVITIS 81 0.0150
255 STOMATITIS 907 0.0149
256 TREATMENT FAILURE 1235 0.0149
257 FULL BLOOD COUNT ABNORMAL 157 0.0148
258 LUMBAR VERTEBRAL FRACTURE 68 0.0148
259 BLOOD PRESSURE INADEQUATELY CONTROLLED 89 0.0148
260 TOOTH INFECTION 195 0.0148
261 EOSINOPHIL COUNT DECREASED 35 0.0147
262 TIBIA FRACTURE 68 0.0145
263 BLOOD CALCIUM INCREASED 127 0.0145
264 SWELLING 1348 0.0144
265 CYST 177 0.0142
266 TONGUE DISORDER 103 0.0142
267 NASAL POLYPS 70 0.0142
268 ROAD TRAFFIC ACCIDENT 588 0.0140
269 PURULENT DISCHARGE 60 0.0140
270 HIATUS HERNIA 181 0.0140
271 LUPUS-LIKE SYNDROME 126 0.0139
272 FIBULA FRACTURE 40 0.0139
273 PUSTULAR PSORIASIS 47 0.0137
274 HYPERTONIC BLADDER 39 0.0135
275 DEFORMITY 126 0.0135
276 HYPERLIPIDAEMIA 161 0.0135
277 BACK INJURY 146 0.0134
278 MASTICATION DISORDER 41 0.0134
279 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 643 0.0134
280 BLOOD CHLORIDE DECREASED 34 0.0132
281 RESPIRATORY RATE INCREASED 117 0.0132
282 ANAL ABSCESS 71 0.0132
283 OESOPHAGEAL PAIN 52 0.0131
284 TOOTH FRACTURE 145 0.0131
285 INTERVERTEBRAL DISC DISORDER 56 0.0131
286 ILL-DEFINED DISORDER 796 0.0131
287 SCOLIOSIS 81 0.0131
288 THYROID NEOPLASM 36 0.0130
289 WEIGHT BEARING DIFFICULTY 35 0.0130
290 ROTATOR CUFF SYNDROME 166 0.0129
291 FEMORAL NECK FRACTURE 66 0.0129
292 SLEEP DISORDER 908 0.0129
293 FEAR OF INJECTION 91 0.0127
294 BLOOD PRESSURE SYSTOLIC DECREASED 58 0.0127
295 INJURY 896 0.0127
296 FRACTURE 241 0.0127
297 ACTINIC KERATOSIS 33 0.0127
298 LIVER FUNCTION TEST INCREASED 272 0.0127
299 CARPAL TUNNEL SYNDROME 174 0.0124
300 BLOOD PARATHYROID HORMONE INCREASED 36 0.0123
301 DELIRIUM 429 0.0123
302 COMPRESSION FRACTURE 66 0.0123
303 JOINT INJURY 262 0.0123
304 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 209 0.0122
305 INTENTIONAL PRODUCT USE ISSUE 1066 0.0122
306 HAND FRACTURE 86 0.0121
307 PULMONARY MASS 180 0.0121
308 TRICUSPID VALVE INCOMPETENCE 96 0.0121
309 HEART RATE DECREASED 424 0.0121
310 EAR PAIN 234 0.0120
311 GINGIVAL SWELLING 53 0.0120
312 ARTHRITIS 943 0.0120
313 NERVE INJURY 133 0.0119
314 NORMAL NEWBORN 65 0.0119
315 GENERAL PHYSICAL HEALTH DETERIORATION 1383 0.0119
316 ARTHRITIS INFECTIVE 55 0.0118
317 SPINAL FUSION SURGERY 48 0.0118
318 HAEMORRHAGIC ANAEMIA 52 0.0118
319 ASPIRATION 129 0.0118
320 TENDONITIS 180 0.0116
321 TOOTH EXTRACTION 144 0.0116
322 MENISCUS INJURY 71 0.0115
323 DRUG ERUPTION 204 0.0115
324 RENAL CYST 91 0.0114
325 DRY MOUTH 929 0.0114
326 OESOPHAGEAL DISORDER 44 0.0114
327 POOR VENOUS ACCESS 117 0.0113
328 FORCED EXPIRATORY VOLUME DECREASED 32 0.0113
329 POSTOPERATIVE WOUND INFECTION 76 0.0112
330 TOOTH ABSCESS 114 0.0112
331 PREGNANCY 223 0.0111
332 MUSCLE FATIGUE 47 0.0111
333 IRON DEFICIENCY ANAEMIA 102 0.0110
334 DIFFICULTY IN WALKING 38 0.0110
335 EMPHYSEMA 111 0.0110
336 SINUSITIS 1120 0.0109
337 CONTUSION 1044 0.0108
338 GASTROINTESTINAL DISORDER 968 0.0108
339 PAIN IN JAW 306 0.0108
340 CATARACT OPERATION 64 0.0108
341 MUSCULOSKELETAL CHEST PAIN 165 0.0106
342 SKIN ULCER 275 0.0106
343 RHINITIS ALLERGIC 47 0.0105
344 RASH VESICULAR 51 0.0105
345 OSTEONECROSIS 346 0.0105
346 HYSTERECTOMY 91 0.0105
347 OXYGEN SATURATION DECREASED 590 0.0105
348 INFECTION 1511 0.0104
349 AORTIC STENOSIS 36 0.0103
350 SPINAL DISORDER 97 0.0102
351 WRIST FRACTURE 122 0.0102
352 SPINAL STENOSIS 42 0.0102
353 RIB FRACTURE 208 0.0101
354 MICTURITION DISORDER 35 0.0101
355 ABDOMINAL TENDERNESS 50 0.0101
356 BONE DENSITY DECREASED 313 0.0100
357 EPILEPSY 305 0.0100
358 GASTROENTERITIS VIRAL 179 0.0099
359 OESOPHAGEAL ULCER 38 0.0099
360 DIVERTICULUM INTESTINAL 43 0.0098
361 APPENDICECTOMY 35 0.0098
362 HYPERTRANSAMINASAEMIA 68 0.0098
363 JOINT STIFFNESS 255 0.0097
364 PERIPHERAL VASCULAR DISORDER 50 0.0097
365 MYOSITIS 87 0.0097
366 RHINITIS 78 0.0097
367 BLOOD POTASSIUM INCREASED 157 0.0097
368 HYPOCALCAEMIA 183 0.0097
369 BONE PAIN 562 0.0096
370 LEFT VENTRICULAR HYPERTROPHY 41 0.0096
371 THROMBOCYTOSIS 35 0.0095
372 OEDEMA PERIPHERAL 1163 0.0095
373 BODY HEIGHT DECREASED 102 0.0095
374 BLOOD TEST ABNORMAL 133 0.0095
375 ARTHRALGIA 3918 0.0094
376 VEIN DISORDER 47 0.0094
377 HYPERTENSION 1989 0.0094
378 EMBOLIC STROKE 33 0.0094
379 PULMONARY CONGESTION 123 0.0093
380 PERIPHERAL SWELLING 1437 0.0093
381 TOOTHACHE 166 0.0092
382 ABDOMINAL DISCOMFORT 1536 0.0091
383 MUSCLE STRAIN 78 0.0090
384 CHEST PAIN 1666 0.0090
385 PHLEBITIS 46 0.0090
386 BONE LESION 32 0.0089
387 HEPATITIS 227 0.0089
388 DISABILITY 173 0.0087
389 CREATININE RENAL CLEARANCE DECREASED 35 0.0087
390 VARICOSE VEIN 44 0.0085
391 LIMB DISCOMFORT 263 0.0085
392 NOCTURIA 103 0.0085
393 MATERNAL EXPOSURE DURING PREGNANCY 755 0.0085
394 AMNESIA 551 0.0085
395 SPINAL FRACTURE 169 0.0084
396 OESOPHAGITIS 92 0.0084
397 DYSPEPSIA 828 0.0084
398 INTERVERTEBRAL DISC PROTRUSION 183 0.0084
399 BACK DISORDER 136 0.0084
400 HYPERKERATOSIS 46 0.0083
401 ECCHYMOSIS 57 0.0083
402 NECK PAIN 464 0.0083
403 HEPATIC CIRRHOSIS 156 0.0083
404 PNEUMONIA 2679 0.0083
405 ANKLE FRACTURE 128 0.0083
406 CANDIDIASIS 33 0.0082
407 AORTIC VALVE INCOMPETENCE 35 0.0082
408 HYPOAESTHESIA 1230 0.0082
409 NASOPHARYNGITIS 1510 0.0082
410 RESPIRATORY DISORDER 245 0.0082
411 MOUTH ULCERATION 171 0.0081
412 ARTHRITIS BACTERIAL 33 0.0080
413 PULMONARY FUNCTION TEST DECREASED 35 0.0080
414 RESPIRATORY TRACT CONGESTION 127 0.0080
415 URINE ODOUR ABNORMAL 47 0.0080
416 PYELONEPHRITIS 69 0.0080
417 RED CELL DISTRIBUTION WIDTH INCREASED 33 0.0079
418 URINE ABNORMALITY 36 0.0079
419 GINGIVAL PAIN 63 0.0079
420 THERAPEUTIC RESPONSE DECREASED 477 0.0079
421 ATELECTASIS 76 0.0079
422 TRANSAMINASES INCREASED 174 0.0078
423 SKIN LACERATION 85 0.0078
424 GASTROENTERITIS 114 0.0078
425 RENAL FAILURE CHRONIC 60 0.0078
426 ORAL DISORDER 57 0.0078
427 SKIN LESION 213 0.0078
428 ABSCESS LIMB 33 0.0077
429 ABDOMINAL PAIN UPPER 1593 0.0077
430 HYPERSENSITIVITY 1433 0.0077
431 MIGRAINE 734 0.0077
432 PROTEIN URINE PRESENT 38 0.0076
433 VITAMIN D DECREASED 65 0.0076
434 WEIGHT FLUCTUATION 79 0.0075
435 BUNDLE BRANCH BLOCK LEFT 32 0.0075
436 SLEEP APNOEA SYNDROME 144 0.0075
437 ORAL HERPES 147 0.0075
438 ESCHERICHIA URINARY TRACT INFECTION 32 0.0075
439 BLOOD CREATININE INCREASED 489 0.0075
440 PAIN IN EXTREMITY 2199 0.0075
441 PURPURA 66 0.0075
442 BRUXISM 40 0.0074
443 PLEURISY 44 0.0074
444 UPPER RESPIRATORY TRACT INFECTION 342 0.0074
445 STOMACH DISCOMFORT 38 0.0073
446 BLOOD PRESSURE INCREASED 1124 0.0073
447 HYPOKALAEMIA 338 0.0073
448 MUSCULAR WEAKNESS 832 0.0073
449 FREQUENT BOWEL MOVEMENTS 197 0.0073
450 HAEMATOCRIT DECREASED 144 0.0073
451 HEPATIC ENZYME ABNORMAL 36 0.0072
452 WEIGHT INCREASED 1615 0.0072
453 HYPOVOLAEMIA 42 0.0072
454 HEART RATE IRREGULAR 162 0.0072
455 LIMB INJURY 194 0.0071
456 KIDNEY INFECTION 140 0.0071
457 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 506 0.0071
458 EAR INFECTION 189 0.0071
459 LIGAMENT SPRAIN 70 0.0071
460 ANOREXIA 91 0.0071
461 HIP FRACTURE 227 0.0071
462 ARTERIOSCLEROSIS 66 0.0070
463 ALOPECIA 1375 0.0070
464 INTERSTITIAL LUNG DISEASE 339 0.0070
465 BLOOD IRON DECREASED 83 0.0070
466 HAEMORRHOIDS 136 0.0070
467 CONFUSIONAL STATE 1126 0.0070
468 SINUS CONGESTION 94 0.0070
469 VASCULITIS 81 0.0069
470 MYOPATHY 60 0.0069
471 HEPATIC STEATOSIS 129 0.0069
472 MITRAL VALVE INCOMPETENCE 78 0.0069
473 CARDIOMEGALY 84 0.0068
474 CARDIAC MURMUR 59 0.0068
475 URTICARIA 1136 0.0068
476 PHARYNGOLARYNGEAL PAIN 36 0.0068
477 TENDERNESS 70 0.0067
478 MUSCULOSKELETAL DISCOMFORT 115 0.0067
479 GAMMA-GLUTAMYLTRANSFERASE INCREASED 147 0.0066
480 BACTERIAL INFECTION 123 0.0066
481 CONDITION AGGRAVATED 2001 0.0066
482 GAIT DISTURBANCE 1252 0.0065
483 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 111 0.0065
484 GASTRIC ULCER 124 0.0065
485 VOMITING 3055 0.0065
486 RASH PRURITIC 352 0.0065
487 HYPERGLYCAEMIA 236 0.0065
488 LOCALISED INFECTION 156 0.0064
489 DEVICE FAILURE 98 0.0064
490 UPPER-AIRWAY COUGH SYNDROME 53 0.0064
491 DYSPNOEA EXERTIONAL 241 0.0064
492 PARAESTHESIA 1003 0.0064
493 CELLULITIS 321 0.0064
494 LARGE INTESTINE POLYP 44 0.0063
495 CYSTITIS 202 0.0063
496 HERPES ZOSTER 361 0.0063
497 BRONCHITIS 465 0.0063
498 PAIN 3854 0.0063
499 CLOSTRIDIUM DIFFICILE COLITIS 66 0.0062
500 IMPAIRED WORK ABILITY 133 0.0062
501 GASTRITIS 163 0.0062
502 APHTHOUS ULCER 48 0.0062
503 ARTERIOSCLEROSIS CORONARY ARTERY 41 0.0062
504 DIVERTICULITIS 171 0.0062
505 BLOOD ALKALINE PHOSPHATASE INCREASED 153 0.0062
506 MEDICATION ERROR 342 0.0061
507 ADVERSE EVENT 566 0.0061
508 FALL 2041 0.0061
509 PLEURAL EFFUSION 373 0.0061
510 BREAST MASS 41 0.0061
511 DIABETES MELLITUS INADEQUATE CONTROL 108 0.0061
512 EXPOSURE DURING PREGNANCY 378 0.0061
513 NERVE COMPRESSION 56 0.0061
514 SKIN INFECTION 68 0.0061
515 COUGH 1696 0.0060
516 CATARACT 359 0.0060
517 SECRETION DISCHARGE 75 0.0060
518 HYPOTHYROIDISM 191 0.0060
519 GLAUCOMA 115 0.0060
520 WHITE BLOOD CELL COUNT INCREASED 229 0.0060
521 MUSCULOSKELETAL DISORDER 113 0.0059
522 ADVERSE DRUG REACTION 533 0.0059
523 ASPARTATE AMINOTRANSFERASE INCREASED 315 0.0059
524 DECREASED APPETITE 1371 0.0059
525 ABSCESS 94 0.0059
526 PRODUCTIVE COUGH 281 0.0059
527 ABDOMINAL PAIN 1360 0.0058
528 INJECTION SITE EXTRAVASATION 72 0.0058
529 TENDON RUPTURE 72 0.0058
530 DUODENAL ULCER 41 0.0058
531 MALAISE 2515 0.0057
532 NEURALGIA 139 0.0057
533 CHOLECYSTECTOMY 65 0.0057
534 ENTERITIS 36 0.0056
535 UPPER LIMB FRACTURE 112 0.0056
536 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 293 0.0056
537 ALANINE AMINOTRANSFERASE INCREASED 344 0.0056
538 BACK PAIN 1301 0.0056
539 MUSCLE SPASMS 1027 0.0056
540 ACTIVITIES OF DAILY LIVING IMPAIRED 110 0.0055
541 PRODUCT USE ISSUE 1039 0.0055
542 DYSPNOEA 3119 0.0055
543 HEART RATE INCREASED 542 0.0055
544 NEUTROPHIL COUNT INCREASED 56 0.0055
545 WEIGHT DECREASED 1519 0.0054
546 MEMORY IMPAIRMENT 746 0.0054
547 ABASIA 134 0.0054
548 SEPTIC SHOCK 235 0.0054
549 BODY TEMPERATURE INCREASED 110 0.0054
550 HERPES SIMPLEX 35 0.0054
551 HUNGER 75 0.0054
552 ASTHENIA 2013 0.0053
553 RECTAL HAEMORRHAGE 230 0.0053
554 HYPOGAMMAGLOBULINAEMIA 35 0.0053
555 MASS 74 0.0053
556 HAEMOPTYSIS 147 0.0053
557 BONE LOSS 79 0.0052
558 MULTIPLE FRACTURES 86 0.0052
559 PYREXIA 1805 0.0052
560 PHARYNGITIS 64 0.0052
561 BLOOD CALCIUM DECREASED 58 0.0052
562 DEPRESSION 1159 0.0051
563 BLOOD ALBUMIN DECREASED 40 0.0050
564 POST PROCEDURAL INFECTION 41 0.0050
565 BLADDER DISORDER 50 0.0050
566 MACULAR DEGENERATION 60 0.0050
567 BLOOD UREA INCREASED 84 0.0050
568 DRY EYE 249 0.0050
569 MYALGIA 847 0.0050
570 LYMPHOEDEMA 34 0.0049
571 NEPHROLITHIASIS 225 0.0049
572 OVARIAN CYST 49 0.0049
573 CHOLELITHIASIS 160 0.0049
574 ORAL PAIN 109 0.0049
575 FACIAL PAIN 43 0.0048
576 BLOOD COUNT ABNORMAL 73 0.0048
577 GENERAL SYMPTOM 36 0.0048
578 PNEUMONIA BACTERIAL 44 0.0048
579 GENERALISED OEDEMA 59 0.0048
580 LYMPHOCYTE COUNT DECREASED 84 0.0047
581 COLITIS ISCHAEMIC 32 0.0047
582 TOOTH LOSS 98 0.0047
583 RENAL PAIN 50 0.0047
584 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
585 MUSCLE DISORDER 38 0.0047
586 MYOCARDIAL ISCHAEMIA 53 0.0047
587 DRUG-INDUCED LIVER INJURY 146 0.0046
588 FEELING HOT 282 0.0046
589 INSOMNIA 1223 0.0046
590 DEAFNESS 120 0.0046
591 SQUAMOUS CELL CARCINOMA 43 0.0046
592 FAECES DISCOLOURED 99 0.0046
593 ORAL CANDIDIASIS 60 0.0046
594 GINGIVAL BLEEDING 62 0.0045
595 URINARY TRACT INFECTION 772 0.0045
596 GASTRIC DISORDER 155 0.0045
597 MYASTHENIA GRAVIS 36 0.0045
598 HYPONATRAEMIA 250 0.0044
599 CHILLS 519 0.0044
600 IMMUNOSUPPRESSION 39 0.0044
601 NEPHROPATHY 41 0.0044
602 COELIAC DISEASE 43 0.0044
603 DIARRHOEA 2829 0.0044
604 SCAR 75 0.0044
605 PLATELET COUNT INCREASED 57 0.0044
606 PNEUMOTHORAX 69 0.0043
607 DYSSTASIA 127 0.0043
608 COLITIS ULCERATIVE 194 0.0043
609 VENTRICULAR EXTRASYSTOLES 45 0.0043
610 CANDIDA INFECTION 73 0.0043
611 URINARY INCONTINENCE 128 0.0043
612 SEASONAL ALLERGY 61 0.0043
613 HYPOPHAGIA 110 0.0043
614 HYPOXIA 151 0.0043
615 PHARMACEUTICAL PRODUCT COMPLAINT 111 0.0043
616 MOVEMENT DISORDER 137 0.0043
617 HEAD INJURY 135 0.0043
618 AGRANULOCYTOSIS 79 0.0042
619 RASH 1848 0.0042
620 ATRIAL FIBRILLATION 412 0.0042
621 CHEST DISCOMFORT 432 0.0042
622 ANXIETY 1195 0.0042
623 SKIN DISORDER 140 0.0042
624 ORTHOSTATIC HYPOTENSION 73 0.0042
625 TRANSIENT ISCHAEMIC ATTACK 141 0.0042
626 DECUBITUS ULCER 34 0.0042
627 SKIN CANCER 89 0.0041
628 INCREASED TENDENCY TO BRUISE 38 0.0041
629 ANGINA PECTORIS 118 0.0041
630 BLOOD LACTATE DEHYDROGENASE INCREASED 65 0.0041
631 RED BLOOD CELL COUNT DECREASED 117 0.0041
632 HERNIA 79 0.0041
633 ARTERIAL OCCLUSIVE DISEASE 32 0.0041
634 FLANK PAIN 38 0.0040
635 SENSORY DISTURBANCE 65 0.0040
636 NASAL CONGESTION 237 0.0040
637 DIZZINESS POSTURAL 39 0.0040
638 DIZZINESS 1995 0.0040
639 BALANCE DISORDER 345 0.0040
640 FUNGAL INFECTION 133 0.0040
641 SMALL INTESTINAL OBSTRUCTION 49 0.0040
642 HAEMATOMA 103 0.0040
643 LUNG INFILTRATION 35 0.0040
644 RESTLESS LEGS SYNDROME 72 0.0040
645 ELECTROLYTE IMBALANCE 46 0.0040
646 HYPOTENSION 794 0.0040
647 POST PROCEDURAL COMPLICATION 76 0.0040
648 THYROID DISORDER 61 0.0040
649 BLOOD PRESSURE DECREASED 262 0.0039
650 NAUSEA 3115 0.0039
651 LACERATION 37 0.0039
652 FATIGUE 3063 0.0039
653 FLUID RETENTION 200 0.0039
654 PANCREATITIS 207 0.0039
655 HAEMOGLOBIN DECREASED 402 0.0039
656 TRANSFUSION 41 0.0039
657 UVEITIS 53 0.0039
658 CORONARY ARTERY DISEASE 118 0.0039
659 EYE INFECTION 44 0.0039
660 BLOOD POTASSIUM DECREASED 117 0.0039
661 RENAL FAILURE ACUTE 165 0.0039
662 DYSPHAGIA 369 0.0039
663 HEADACHE 2433 0.0039
664 EYE INFLAMMATION 37 0.0039
665 ERUCTATION 75 0.0039
666 SPINAL PAIN 45 0.0038
667 DRY THROAT 39 0.0038
668 ABDOMINAL DISTENSION 399 0.0038
669 LYMPHOMA 59 0.0038
670 LIVER FUNCTION TEST ABNORMAL 111 0.0038
671 UPPER GASTROINTESTINAL HAEMORRHAGE 64 0.0038
672 MIDDLE INSOMNIA 71 0.0038
673 OROPHARYNGEAL PAIN 350 0.0038
674 CONJUNCTIVITIS 70 0.0038
675 ADVERSE REACTION 50 0.0038
676 LOSS OF CONSCIOUSNESS 478 0.0037
677 LYMPHADENOPATHY 132 0.0037
678 EAR DISCOMFORT 38 0.0037
679 ANAEMIA 704 0.0037
680 SINUS DISORDER 73 0.0037
681 PNEUMOCYSTIS JIROVECII PNEUMONIA 37 0.0037
682 THROAT IRRITATION 164 0.0037
683 QUALITY OF LIFE DECREASED 49 0.0036
684 LEUKOCYTOSIS 66 0.0036
685 SCAB 41 0.0036
686 INFLUENZA 399 0.0036
687 CLOSTRIDIUM DIFFICILE INFECTION 78 0.0036
688 INFLUENZA LIKE ILLNESS 292 0.0035
689 VERTIGO 216 0.0035
690 RHINORRHOEA 228 0.0035
691 HEPATOCELLULAR INJURY 50 0.0035
692 HYPOMAGNESAEMIA 49 0.0035
693 LOCAL SWELLING 61 0.0035
694 RENAL IMPAIRMENT 293 0.0035
695 MALNUTRITION 39 0.0035
696 HEMIPARESIS 59 0.0035
697 SKELETAL INJURY 36 0.0035
698 GALLBLADDER DISORDER 62 0.0035
699 FISTULA 39 0.0035
700 PHOTOPHOBIA 65 0.0035
701 APPENDICITIS 32 0.0034
702 OFF LABEL USE 2990 0.0034
703 LACRIMATION INCREASED 103 0.0034
704 PULMONARY HYPERTENSION 71 0.0034
705 TREATMENT NONCOMPLIANCE 186 0.0034
706 PARAESTHESIA ORAL 49 0.0034
707 ILEUS 42 0.0034
708 CHOLECYSTITIS 40 0.0034
709 COLON CANCER 50 0.0034
710 METASTASES TO CENTRAL NERVOUS SYSTEM 43 0.0033
711 CHOLESTASIS 64 0.0033
712 DYSPHONIA 194 0.0033
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 95 0.0033
714 INTESTINAL PERFORATION 37 0.0033
715 EATING DISORDER 70 0.0033
716 DEEP VEIN THROMBOSIS 212 0.0033
717 COGNITIVE DISORDER 152 0.0033
718 DEPRESSED MOOD 172 0.0033
719 MICTURITION URGENCY 37 0.0032
720 THERAPY PARTIAL RESPONDER 50 0.0032
721 BLOOD BILIRUBIN INCREASED 86 0.0032
722 PRODUCT USE IN UNAPPROVED INDICATION 785 0.0032
723 LEUKOPENIA 158 0.0032
724 STAPHYLOCOCCAL INFECTION 104 0.0031
725 EYELID PTOSIS 32 0.0031
726 MELAENA 69 0.0031
727 CONSTIPATION 683 0.0031
728 LABORATORY TEST ABNORMAL 92 0.0031
729 JAUNDICE 83 0.0031
730 EOSINOPHILIA 54 0.0031
731 EYE DISCHARGE 32 0.0031
732 BLOOD PRESSURE ABNORMAL 61 0.0031
733 ERYTHEMA 628 0.0031
734 INJECTION SITE REACTION 210 0.0030
735 PRURITUS 1169 0.0030
736 ECONOMIC PROBLEM 46 0.0030
737 VIRAL INFECTION 101 0.0030
738 PRODUCT QUALITY ISSUE 412 0.0030
739 DIABETES MELLITUS 231 0.0030
740 SARS-COV-2 TEST POSITIVE 40 0.0030
741 BLOOD SODIUM DECREASED 57 0.0030
742 PALPITATIONS 352 0.0030
743 PERITONITIS 62 0.0030
744 DEVICE RELATED INFECTION 46 0.0030
745 PERIPHERAL COLDNESS 41 0.0030
746 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
747 SKIN DISCOLOURATION 137 0.0030
748 PHOTOSENSITIVITY REACTION 49 0.0030
749 HAEMATEMESIS 75 0.0030
750 ECZEMA 153 0.0029
751 MUSCLE ATROPHY 37 0.0029
752 INTESTINAL OBSTRUCTION 110 0.0029
753 HAEMATOCHEZIA 160 0.0029
754 NEUROPATHY PERIPHERAL 275 0.0029
755 HEAD DISCOMFORT 51 0.0029
756 NO THERAPEUTIC RESPONSE 35 0.0029
757 DRUG INEFFECTIVE 3780 0.0029
758 ARRHYTHMIA 135 0.0028
759 ANAPHYLACTIC SHOCK 73 0.0028
760 PSORIASIS 369 0.0028
761 ACUTE MYOCARDIAL INFARCTION 83 0.0028
762 PROCEDURAL PAIN 78 0.0028
763 SUBDURAL HAEMATOMA 40 0.0028
764 PANCYTOPENIA 156 0.0028
765 DIPLOPIA 72 0.0028
766 MUSCLE SPASTICITY 34 0.0028
767 MYOCARDIAL INFARCTION 481 0.0028
768 HYPOKINESIA 40 0.0028
769 FLATULENCE 155 0.0027
770 INFUSION SITE PAIN 35 0.0027
771 MUSCLE TIGHTNESS 44 0.0027
772 EYE PRURITUS 91 0.0027
773 CORONARY ARTERY OCCLUSION 37 0.0027
774 ASCITES 79 0.0027
775 INCREASED APPETITE 51 0.0027
776 BRONCHOSPASM 38 0.0027
777 MULTI-ORGAN FAILURE 46 0.0027
778 EYE PAIN 150 0.0027
779 PELVIC PAIN 48 0.0026
780 PNEUMONIA ASPIRATION 66 0.0026
781 BLOOD URINE PRESENT 50 0.0026
782 PULMONARY EMBOLISM 250 0.0026
783 HEPATIC FUNCTION ABNORMAL 98 0.0026
784 HYPERTHYROIDISM 38 0.0026
785 VISUAL ACUITY REDUCED 87 0.0026
786 HYPOGLYCAEMIA 126 0.0026
787 CARDIAC FAILURE CONGESTIVE 208 0.0026
788 HYPOAESTHESIA ORAL 39 0.0026
789 TREMOR 428 0.0026
790 CEREBRAL INFARCTION 63 0.0026
791 PNEUMONITIS 70 0.0026
792 UNDERDOSE 187 0.0026
793 MYELODYSPLASTIC SYNDROME 37 0.0026
794 LUNG NEOPLASM MALIGNANT 105 0.0026
795 DYSURIA 94 0.0026
796 PERICARDIAL EFFUSION 59 0.0025
797 SINUS TACHYCARDIA 36 0.0025
798 TACHYCARDIA 225 0.0025
799 CHROMATURIA 57 0.0025
800 TINNITUS 116 0.0025
801 POLLAKIURIA 105 0.0025
802 GASTROINTESTINAL HAEMORRHAGE 210 0.0025
803 PRESYNCOPE 61 0.0025
804 GOUT 45 0.0025
805 MUSCLE TWITCHING 57 0.0025
806 LUNG INFECTION 38 0.0024
807 AGEUSIA 61 0.0024
808 HOT FLUSH 184 0.0024
809 CARDIOMYOPATHY 36 0.0024
810 PULMONARY OEDEMA 109 0.0024
811 SYNCOPE 243 0.0024
812 ANOSMIA 35 0.0024
813 DEHYDRATION 321 0.0024
814 RESPIRATORY DISTRESS 66 0.0024
815 DERMATITIS 50 0.0024
816 SWELLING FACE 155 0.0024
817 HYPERHIDROSIS 306 0.0024
818 DRUG LEVEL INCREASED 39 0.0024
819 DISEASE RECURRENCE 112 0.0024
820 INTERNATIONAL NORMALISED RATIO INCREASED 67 0.0023
821 VISUAL IMPAIRMENT 291 0.0023
822 THROMBOCYTOPENIA 262 0.0023
823 MENTAL STATUS CHANGES 65 0.0023
824 BRADYCARDIA 124 0.0023
825 LETHARGY 134 0.0023
826 RESPIRATORY FAILURE 169 0.0023
827 CARDIAC FAILURE 186 0.0023
828 CARDIAC DISORDER 216 0.0023
829 FEELING COLD 64 0.0023
830 GLYCOSYLATED HAEMOGLOBIN INCREASED 58 0.0023
831 ISCHAEMIC STROKE 41 0.0023
832 APHONIA 32 0.0023
833 CONVULSION 131 0.0023
834 APHASIA 69 0.0023
835 BREAST CANCER FEMALE 61 0.0023
836 HAEMATURIA 78 0.0023
837 RENAL FAILURE 302 0.0023
838 FEAR 61 0.0023
839 CHOKING 44 0.0023
840 SEPSIS 251 0.0022
841 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
842 THROMBOSIS 180 0.0022
843 EYE DISORDER 73 0.0022
844 EYE SWELLING 82 0.0022
845 THROAT TIGHTNESS 59 0.0022
846 DISORIENTATION 86 0.0022
847 RENAL DISORDER 101 0.0022
848 BURNING SENSATION 152 0.0022
849 FLUSHING 220 0.0022
850 NERVOUSNESS 113 0.0022
851 METASTASES TO LIVER 38 0.0022
852 RASH ERYTHEMATOUS 103 0.0022
853 EPISTAXIS 160 0.0021
854 POOR QUALITY SLEEP 46 0.0021
855 COLITIS 81 0.0021
856 HEPATOTOXICITY 47 0.0021
857 URINARY RETENTION 70 0.0021
858 ABDOMINAL PAIN LOWER 53 0.0021
859 CHRONIC KIDNEY DISEASE 159 0.0021
860 RASH GENERALISED 54 0.0021
861 RETCHING 44 0.0021
862 WHITE BLOOD CELL COUNT DECREASED 223 0.0021
863 PROTEINURIA 39 0.0020
864 DYSGEUSIA 152 0.0020
865 SPEECH DISORDER 107 0.0020
866 END STAGE RENAL DISEASE 37 0.0020
867 RASH MACULO-PAPULAR 45 0.0020
868 RESTLESSNESS 74 0.0020
869 METASTASES TO BONE 33 0.0020
870 OCULAR HYPERAEMIA 95 0.0020
871 RHABDOMYOLYSIS 82 0.0020
872 ENCEPHALOPATHY 48 0.0020
873 PALLOR 53 0.0019
874 PRURITUS GENERALISED 42 0.0019
875 HYPERKALAEMIA 68 0.0019
876 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
877 VISION BLURRED 265 0.0019
878 ACUTE RESPIRATORY FAILURE 37 0.0019
879 BLINDNESS 78 0.0019
880 CEREBROVASCULAR ACCIDENT 324 0.0019
881 FEELING ABNORMAL 448 0.0019
882 FEBRILE NEUTROPENIA 124 0.0019
883 ACUTE KIDNEY INJURY 284 0.0019
884 SOMNOLENCE 371 0.0018
885 NERVOUS SYSTEM DISORDER 57 0.0018
886 SHOCK 42 0.0018
887 SURGERY 107 0.0018
888 BLOOD TRIGLYCERIDES INCREASED 32 0.0018
889 PANIC ATTACK 66 0.0018
890 BREAST CANCER 168 0.0018
891 HALLUCINATION, VISUAL 38 0.0018
892 DEMENTIA 50 0.0018
893 ANHEDONIA 47 0.0018
894 THERAPEUTIC RESPONSE SHORTENED 59 0.0018
895 HYPERSOMNIA 51 0.0018
896 RASH MACULAR 62 0.0018
897 LIP SWELLING 59 0.0018
898 SWOLLEN TONGUE 55 0.0018
899 DRUG INTERACTION 279 0.0018
900 FEEDING DISORDER 35 0.0017
901 RASH PAPULAR 38 0.0017
902 INJECTION SITE HAEMORRHAGE 135 0.0017
903 BLOOD GLUCOSE INCREASED 314 0.0017
904 PLATELET COUNT DECREASED 175 0.0016
905 ABNORMAL DREAMS 45 0.0016
906 CARDIO-RESPIRATORY ARREST 68 0.0016
907 INCORRECT PRODUCT ADMINISTRATION DURATION 35 0.0016
908 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 290 0.0016
909 HOSPITALISATION 246 0.0016
910 WRONG TECHNIQUE IN DRUG USAGE PROCESS 58 0.0016
911 BLOOD GLUCOSE DECREASED 75 0.0016
912 DRUG EFFECT DECREASED 83 0.0015
913 THERAPEUTIC RESPONSE UNEXPECTED 69 0.0015
914 CEREBRAL HAEMORRHAGE 55 0.0015
915 METABOLIC ACIDOSIS 49 0.0015
916 STEVENS-JOHNSON SYNDROME 34 0.0015
917 MUCOSAL INFLAMMATION 40 0.0015
918 EMOTIONAL DISTRESS 184 0.0015
919 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 108 0.0015
920 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43 0.0015
921 SNEEZING 34 0.0015
922 EYE IRRITATION 86 0.0015
923 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
924 PRODUCT PRESCRIBING ERROR 35 0.0015
925 PANCREATITIS ACUTE 33 0.0015
926 DRUG ADMINISTRATION ERROR 45 0.0015
927 HAEMORRHAGE 153 0.0015
928 HYPOACUSIS 63 0.0015
929 ANGIOEDEMA 64 0.0014
930 NEUTROPENIA 196 0.0014
931 DYSKINESIA 58 0.0014
932 ILLNESS 147 0.0014
933 HEPATIC FAILURE 43 0.0014
934 NEOPLASM MALIGNANT 95 0.0014
935 CARDIOVASCULAR DISORDER 36 0.0014
936 HALLUCINATION 106 0.0014
937 SEDATION 36 0.0014
938 COVID-19 241 0.0014
939 PRODUCT SUBSTITUTION ISSUE 79 0.0014
940 ANAPHYLACTIC REACTION 75 0.0014
941 DYSARTHRIA 51 0.0014
942 COMA 64 0.0013
943 DEVICE BREAKAGE 54 0.0013
944 NEUTROPHIL COUNT DECREASED 54 0.0013
945 DEVICE DISLOCATION 57 0.0013
946 UNEVALUABLE EVENT 98 0.0013
947 NEEDLE ISSUE 37 0.0013
948 EMOTIONAL DISORDER 38 0.0012
949 DISTURBANCE IN ATTENTION 66 0.0012
950 MULTIPLE SCLEROSIS 58 0.0012
951 ELECTROCARDIOGRAM QT PROLONGED 42 0.0012
952 GYNAECOMASTIA 36 0.0012
953 AGITATION 84 0.0011
954 INJECTION SITE ERYTHEMA 141 0.0011
955 ACCIDENTAL OVERDOSE 41 0.0011
956 INTENTIONAL PRODUCT MISUSE 96 0.0011
957 INJECTION SITE MASS 40 0.0011
958 CRYING 39 0.0011
959 MENTAL DISORDER 46 0.0011
960 INJECTION SITE SWELLING 80 0.0010
961 PRODUCT DOSE OMISSION ISSUE 306 0.0010
962 OVERDOSE 212 0.0010
963 INCORRECT DOSE ADMINISTERED 224 0.0010
964 NIGHTMARE 33 0.0010
965 DRY SKIN 124 0.0009
966 IRRITABILITY 55 0.0009
967 CARDIAC ARREST 75 0.0009
968 DRUG EFFECT INCOMPLETE 32 0.0009
969 INJECTION SITE PRURITUS 58 0.0009
970 ACNE 65 0.0009
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
972 INJECTION SITE BRUISING 66 0.0008
973 MALIGNANT NEOPLASM PROGRESSION 83 0.0008
974 INJECTION SITE PAIN 243 0.0008
975 DRUG DOSE OMISSION 126 0.0008
976 SEIZURE 87 0.0008
977 PROSTATE CANCER 60 0.0007
978 SUICIDAL IDEATION 68 0.0007
979 DISEASE PROGRESSION 86 0.0007
980 SKIN EXFOLIATION 61 0.0007
981 MULTIPLE SCLEROSIS RELAPSE 48 0.0007
982 AGGRESSION 35 0.0007
983 DEATH 596 0.0007
984 PRODUCT DOSE OMISSION 38 0.0006
985 SKIN BURNING SENSATION 39 0.0005
986 NO ADVERSE EVENT 98 0.0005
987 FOETAL EXPOSURE DURING PREGNANCY 43 0.0005
988 TOXICITY TO VARIOUS AGENTS 89 0.0005
989 THERAPY INTERRUPTED 33 0.0005
990 DRUG DEPENDENCE 58 0.0004
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 73 0.0004